Profile
International Journal of Clinical & Medical Microbiology Volume 2 (2017), Article ID 2:IJCMM-127, 2 pages
https://doi.org/10.15344/2456-4028/2017/127
Commentary
Molecular Epidemiology of Bloodstream Infection-causing Acinetobacter baumannii from Five Tertiary Hospitals in Beijing, China

Ling Guo1, Chunmei Bao2, Jie Liu3, Xiuhong Hao4, Jingui Cao5, Liyan Ye1 and Jiyong Yang1*

1Department of Microbiology, Chinese PLA General Hospital, Beijing, 100853, China
2Clinical Diagnostic Center, 302nd Hospital of China, 100039, China
3Department of Laboratory, PLA Army General Hospital, Beijing, 100700, China
4Clinical Laboratory, Navy General Hospital, PLA, Beijing, 100048, China
5Department of Infection Control, Air Force General Hospital, PLA, Beijing, 100142, China
Dr. Jiyong Yang, Department of Microbiology, Chinese PLA General Hospital, Beijing, 100853, China, Tel: +86 10 66936575; E-mail: yangjy301@hotmail.com
10 November 2017; 28 December 2017; 30 December 2017
Guo L, Bao C, Liu J, Hao S, Cao J, et al. (2017) Molecular Epidemiology of Bloodstream Infection-causing Acinetobacter baumannii from Five Tertiary Hospitals in Beijing, China. Int J Clin Med Microbiol 2: 127. doi: https://doi.org/10.15344/2456-4028/2017/127

References

  1. Peleg AY, Seifert H, Paterson DL (2008) Acinetobacter baumannii: Emergence of a successful pathogen. Clin Microbiol Rev 21: 538-582 [CrossRef] [Google Scholar] [PubMed]
  2. Falagas ME, Bliziotis IA, Siempos II (2006) Attributable mortality of acinetobacter baumannii infections in critically ill patients: A systematic review of matched cohort and case-control studies. Crit Care 10: R48 [CrossRef] [Google Scholar] [PubMed]
  3. Lee HY, Chen CL, Wu SR, Huang CW, Chiu CH (2014) Risk factors and outcome analysis of acinetobacter baumannii complex bacteremia in critical patients. Crit Care Med 42: 1081-1088 [CrossRef] [Google Scholar] [PubMed]
  4. Lockhart SR, Abramson MA, Beekmann SE, Gallagher G, Riedel S, et al. (2007) Antimicrobial resistance among gram-negative bacilli causing infections in intensive care unit patients in the united states between 1993 and 2004. J Clin Microb 45: 3352-3359 [CrossRef] [Google Scholar] [PubMed]
  5. Durante-Mangoni E, Zarrilli R (2011) Global spread of drug-resistant acinetobacter baumannii: Molecular epidemiology and management of antimicrobial resistance. Future microbiology 6: 407-422 [CrossRef] [Google Scholar] [PubMed]
  6. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, et al. (2012) Multidrug-resistant, extensively drug-resistant and pandrugresistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18: 268-281 [CrossRef] [Google Scholar] [PubMed]
  7. Poirel L, Nordmann P (2006) Carbapenem resistance in acinetobacter baumannii: Mechanisms and epidemiology. Clin Microbiol Infect 12: 826- 836 [CrossRef] [Google Scholar] [PubMed]
  8. Gupta N, Limbago BM, Patel JB, Kallen AJ (2011) Carbapenem-resistant enterobacteriaceae: Epidemiology and prevention. Clin Infect Dis 53: 60- 67 [CrossRef] [Google Scholar] [PubMed]
  9. Walther-Rasmussen J, Hoiby N (2006) Oxa-type carbapenemases. J Antimicrob Chemother 57: 373-383 [CrossRef] [Google Scholar] [PubMed]
  10. Hu WS, Yao SM, Fung CP, Hsieh YP, Liu CP, Lin JF (2007) An oxa-66/ oxa-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in acinetobacter baumannii. Antimicrob Agents Chemother 51: 3844-3852 [CrossRef] [Google Scholar] [PubMed]
  11. Turton JF, Ward ME, Woodford N, et al. (2006) The role of isaba1 in expression of oxa carbapenemase genes in acinetobacter baumannii. FEMS Microbiol Lett 258: 72-77 [CrossRef] [Google Scholar] [PubMed]
  12. Durmaz R, Otlu B, Koksal F, Hosoglu S, Ozturk R, et al. (2009) The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of acinetobacter baumannii, escherichia coli and klebsiella spp. Jpn J Infect Dis 62: 372-377 [Google Scholar] [PubMed]
  13. Woodford N, Ellington MJ, Coelho JM, et al. (2006) Multiplex pcr for genes encoding prevalent oxa carbapenemases in acinetobacter spp. Int J Antimicrob Agents 27: 351-353 [CrossRef] [Google Scholar] [PubMed]
  14. Poirel L, Walsh TR, Cuvillier V, Nordmann P (2011) Multiplex pcr for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70: 119-123 [CrossRef] [Google Scholar] [PubMed]
  15. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S (2010) The population structure of acinetobacter baumannii: Expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 5: e10034 [CrossRef] [Google Scholar] [PubMed]
  16. Dijkshoorn L, Nemec A, Seifert H (2007) An increasing threat in hospitals: Multidrug-resistant acinetobacter baumannii. Nat Rev Microbiol 5: 939-951 [CrossRef] [Google Scholar] [PubMed]
  17. Fu Y, Zhou J, Zhou H, Yang Q, Wei Z, et al. (2010) Wide dissemination of oxa-23-producing carbapenem-resistant acinetobacter baumannii clonal complex 22 in multiple cities of china. J Antimicrob Chemother 65: 644-650 [CrossRef] [Google Scholar] [PubMed]
  18. He C, Xie Y, Fan H, Kang M, Tao C, et al. (2011) Spread of imipenemresistant acinetobacter baumannii of european clone ii in western china. Int J Antimicrob Agents 38: 257-260 [CrossRef] [Google Scholar] [PubMed]
  19. Zhong Q, Xu W, Wu Y, Xu H (2012) Clonal spread of carbapenem nonsusceptible acinetobacter baumannii in an intensive care unit in a teaching hospital in china. Ann Lab Med 32: 413-419 [CrossRef] [Google Scholar] [PubMed]
  20. Huang ST, Chiang MC, Kuo SC, Lee YT, Chiang TH, et al. (2012) Risk factors and clinical outcomes of patients with carbapenem-resistant acinetobacter baumannii bacteremia. J Microbiol Immunol Infect 45: 356- 362 [CrossRef] [Google Scholar] [PubMed]